目的：评价坎地沙坦对老年陈旧前壁心梗合并心衰患者的疗效。
Objective: To assess effects of treatment in elder patients with old anterior wall myocardial infarction used candesartan.
制得的坎地沙坦固体分散体为一稳定体系，具有实际应用价值。
Candesartan SD is a stabilizing system which having actual applied value.
在研究过程中他们没有观察到坎地沙坦使用引起的任何不利影响。
They did not observe any adverse effects of candesartan use over the course of their study.
资料来自坎地沙坦于心衰病死率及发病率减少的评价（CHARM） 。
They used data from the Candersartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme.
本文通过前瞻性的观察探讨坎地沙坦对房颤转复成功率及近期复发率的影响。
The main purpose of this study is to explore the influence of Candesartan on cardioversion and recurrence of Af prospectively.
目的比较酮色林和坎地沙坦对清醒自由活动自发高血压大鼠压力反射功能的影响。
Objective To compare the effect of ketanserin and candesartan on baroreflex in conscious spontaneous hypertensive rats.
本文综述了坎地沙坦在降压、靶器官保护、防治心力衰竭以及冠心病中的近期研究成果。
This review sums up the recent result about candesartan in lowering blood pressure, protecting target organ, treating congestive heart failure and coronary heart disease.
大量临床研究结果表明坎地沙坦可降低心力衰竭病人心血管死亡率和因心力衰竭加重的住院率。
A large number of clinical trials showed that candesartan could reduce the cardiovascular mortality for heart failure and hospitalization for worsening heart failure.
这些研究表明，坎地沙坦是剂量依赖性、抗炎作用是通过抑制NF-B的活性和趋化因子表达介导的。
These findings suggest that candesartan has dosage-dependent, anti-inflammatory effects that are mediated by suppression of NF-B activation and chemokine expression.
一项新的临床试验表明，长期使用坎地沙坦，一种目前用于治疗高血压的药物，可能会显著缓解遗传性心脏病的症状。
A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease.
Bilou教授：根据我们现有的数据，就像今天汇报的那样，还不能说坎地沙坦（Candesatan）对微量白蛋白尿的一级预防是有用的。
Prof. R. W. Bilou: Well, at the moment from our data as presented today we can't say that Candesatan has a role for the primary prevention of microalbuminuria.
Bilou教授：根据我们现有的数据，就像今天汇报的那样，还不能说坎地沙坦（Candesatan）对微量白蛋白尿的一级预防是有用的。
Prof. R. W. Bilou: Well, at the moment from our data as presented today we can't say that Candesatan has a role for the primary prevention of microalbuminuria.
应用推荐